Donate to Illuminate Order Brochures Contact TSF
Facebook Logo Twitter Logo Youtube Logo Instagram Logo LinkedIn Logo TikTok Logo Blue Sky Logo

Choose Your Language:

ACT with NMOSD – Mental Health Treatment & Resources

ACT with NMOSD is a specialized mental health program designed to support individuals living with NMOSD in managing the psychological impact of the disease and improving overall quality of life.

This 6-week, telehealth-based program has been shown to reduce symptoms of depression and anxiety, while enhancing psychological flexibility, values-based living and sleep quality in adults with NMOSD. Benefits have been observed to persist for at least 3 months following completion of the program.

Delivered in weekly 1-hour sessions with a licensed mental health professional, ACT with NMOSD is an engaging, structured intervention developed through extensive research on the psychological burden of NMOSD, including patient interviews and focus groups.


Directory of Certified Clinicians (US only)

Building on the demonstrated benefits of ACT with NMOSD, colleagues at Thomas Jefferson University have trained 13 mental health providers across the United States in this specialized protocol. This certification process is highly rigorous and includes several days of live and recorded instruction, a written examination and adherence coding of all 6 ACT with NMOSD sessions. Certified providers continue to receive ongoing monthly consultation with the program’s developer, Dr. V. O’Hayer.

Below is a directory of clinicians certified in ACT with NMOSD. Please check which providers are licensed to practice in your state. If you are unable to find a provider licensed in your area, you may contact [email protected] to learn more about whether you or your loved one with NMOSD may be eligible to participate in the ongoing ACT with NMOSD clinical trial.

Eligibility Criteria

ACT with NMOSD Certified Mental Health Providers

ACT with NMOSD Certified Mental Health Providers

These providers are trained in Acceptance and Commitment Therapy (ACT) specifically for people living with Neuromyelitis Optica Spectrum Disorder (NMOSD). Use the filters below to find a provider near you.

Lisa Fitzgibbons
Arkansas (AR)
✓ PSYPACT Licensed
Joey Cheung
Illinois & California (IL, CA)
Not PSYPACT Licensed
Chris Drescher
Georgia (GA)
✓ PSYPACT Licensed
Matthew Kridel
Georgia (GA)
✓ PSYPACT Licensed
Jordyn Anderson, PsyD
New York & New Jersey (NY, NJ)
⏳ PSYPACT Application Pending
Katherine Chapman
Texas (TX)
Not PSYPACT Licensed
Jenn Palau
Washington & California (WA, CA)
Not PSYPACT Licensed
Heather Bruschwein
Virginia (VA)
Not PSYPACT Licensed
Krista Ingle
North Carolina (NC)
✓ PSYPACT Licensed
Joanna Chen
California (CA)
Not PSYPACT Licensed
Patrick Smith
North Carolina (NC)
Not PSYPACT Licensed
Ann Lantagne
Colorado (CO)
✓ PSYPACT Licensed
Max Genecov
Pennsylvania (PA)
Not PSYPACT Licensed
No providers match your current filters. Try broadening your search.
What is PSYPACT? PSYPACT-licensed providers can see patients across state lines in participating states — meaning you may be able to work with them remotely even if they’re not licensed in your state. Because membership grows each year, check psypact.gov for the current list of participating states.

SMART NMO Tool

Colleagues at Thomas Jefferson University have developed and validated a self-report measure designed to assess the specific psychological burden associated with NMOSD. This tool, known as SMART NMO (Systematic Mental Health Assessment & Response Tool for NMOSD), is available in two versions: one for individuals living with NMOSD and one for caregivers or loved ones.

Below are links to the SMART NMO assessment tool, designed to help individuals with NMOSD and their loved ones better understand their psychological wellbeing. Completing this assessment may help determine whether you could benefit from a mental health program such as ACT with NMOSD.


Both the ACT with NMOSD study and the Psychological Burden of NMOSD study were supported by grants from Alexion AstraZeneca Rare Disease.